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Pathogenic mutations in the non-syndromic hearing loss and deafness 1 (DFNB1)
locus are the primary cause of monogenic inheritance for prelingual hearing loss. To
unravel molecular pathways involved in etiopathology and look for early degeneration
biomarkers, we used a system biology approach to analyze Cx30−/− mice at an early
cochlear post-natal developmental stage. These mice are a DFNB1 mouse model
with severely reduced expression levels of two connexins in the inner ear, Cx30, and
Cx26. Integrated analysis of miRNA and mRNA expression profiles in the cochleae of
Cx30−/− mice at post-natal day 5 revealed the overexpression of five miRNAs (miR-34c,
miR-29b, miR-29c, miR-141, and miR-181a) linked to apoptosis, oxidative stress, and
cochlear degeneration, which have Sirt1 as a common target of transcriptional and/or
post-transcriptional regulation. In young adult Cx30−/− mice (3 months of age), these
alterations culminated with blood barrier disruption in the Stria vascularis (SV ), which
is known to have the highest aerobic metabolic rate of all cochlear structures and
whose microvascular alterations contribute to age-related degeneration and progressive
decline of auditory function. Our experimental validation of selected targets links hearing
acquisition failure in Cx30−/− mice, early oxidative stress, and metabolic dysregulation
to the activation of the Sirt1–p53 axis. This is the first integrated analysis of miRNA
and mRNA in the cochlea of the Cx30−/− mouse model, providing evidence that
connexin downregulation determines a miRNA-mediated response which leads to
chronic exhaustion of cochlear antioxidant defense mechanisms and consequent SV
dysfunction. Our analyses support the notion that connexin dysfunction intervenes early
on during development, causing vascular damage later on in life. This study identifies also
early miRNA-mediated biomarkers of hearing impairment, either inherited or age related.
Keywords: connexins, molecular pathway analysis, early degeneration, systems biology, hearing loss, vascular
dysfunction, post-natal development, oxidative stress
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INTRODUCTION
Cx26 and Cx30 are the prevailing gap junction proteins in
the duct of the developing and mature mammalian cochlea
(Mammano, 2019). Pathogenic mutations in the DFNB1 locus,
which contains both genes (GJB2/CX26 and GJB6/CX30)
encoding these connexins, are the primary cause of monogenic
inheritance for prelingual deafness. It remains unclear if
their coordinated expression is due to digenic inheritance or
mutations affecting cis-regulatory elements that in turn influence
GJB2/CX26 expression (Del Castillo and Del Castillo, 2017).
Knockout mouse models confirmed the essential role of
inner ear connexins for hearing, since their absence causes
profound deafness associated with apoptotic processes within
the developing organ of Corti (OC) (Teubner et al., 2003).
Cx30 homozygous knockout-LacZ mice (Gjb6tm1Kwi/Gjb6tm1Kwi;
MGI:2447863; EM:00323), hereafter abbreviated as Cx30−/−, are
a model for humans in which large deletions in the DFNB1 locus
lead to downregulation of both GJB2/CX26 and GJB6/CX30 and
profound deafness. Cx30−/− mice exhibit (i) severe constitutive
hearing impairment with degeneration of cochlear sensory
epithelium from post-natal day 18 (P18) onwards, (ii) absence
of endocochlear potential (Teubner et al., 2003), and (iii)
defects of the endothelial barrier in capillaries of the stria
vascularis (SV) (Cohen-Salmon et al., 2007). In addition, massive
downregulation of Cx26, at both mRNA and protein levels, was
reported in the developing OC of Cx30−/− mice at P5 in non-
sensory cells located between outer hair cells and SV (Ortolano
et al., 2008); both transcript and protein levels of Cx26 were
similarly reduced in the cochleae ofCx30−/− mice at P30 (Boulay
et al., 2013).
The coordinated regulation of Cx26 and Cx30 expression
in the cochlea apparently occurs as a result of NFκB
pathway signaling, as it could be inhibited by expressing a
stable form of the IκB repressor protein that prevents the
activation/translocation of NFκB (Ortolano et al., 2008). The
amplitude and duration of Ca2+ signals control differential
activation of NFκB (Dolmetsch et al., 1998), and prior works
linked alterations of Ca2+ signaling to hearing loss in transgenic
mice (Schutz et al., 2010; Rodriguez et al., 2012). Other published
data linked defective hearing acquisition to impairment of
ATP- and IP3-dependent Ca
2+ signaling in non-sensory cells
of the developing cochlea (Ceriani et al., 2016), identified inner
ear connexins as both targets and effectors of these signaling
mechanisms, and support the notion that connexin dysfunction
intervenes early on during development, calling for a timely
therapeutic intervention (Crispino et al., 2011).
Recently, the emerging role of microRNAs (miRNAs) in
post-transcriptional gene expression regulation has also been
investigated using knockout mouse models whose miRNA
deregulated profiles may suggest a potential contribution to
Abbreviations: ARHL, Age-related hearing loss; DEG, Differentially expressed
gene; DFNB1, Non-syndromic hearing loss and deafness 1; ER, Endoplasmic
reticulum; GO, Gene ontology; GEO, Gene Expression Omnibus; m, Post-natal
month; MAM, Mitochondria-associated membrane; miRNA, MicroRNA; OC,
Organ of Corti; P, Post-natal day; PPI, Protein–protein interaction; SERCA,
Sarcoplasmic/endoplasmic reticulum calcium ATPase; SV, Stria vascularis.
cochlear pathogenesis (Elkan-Miller et al., 2011; Patel and Hu,
2012; Ushakov et al., 2013; Zhang et al., 2013; Mahmoodian sani
et al., 2016; Mittal et al., 2019). In addition, deficiency of Cx26 in
Gjb2/Cx26 conditional knockout mice was linked to an impaired
miRNA-mediated intercellular communication through cochlear
gap junctions (Zhu et al., 2015).
Here, we explored mechanisms underlying the
etiopathogenesis of DFNB1 by performing an integrated
genomics analysis of miRNA and mRNA expression profiles
in Cx30−/− mice. In a prior work, transcriptomic profiles of
Cx30−/− mice (and their wild-type siblings) were obtained
at P13, highlighting a significant downregulation of betaine
homocysteine S-methyltransferase (Bhmt) restricted to the SV,
followed by the consequent local increase of homocysteine
level and endothelial barrier dysfunction (Cohen-Salmon
et al., 2007). In this study, we extended those results by also
investigating miRNA-mediated regulation at an earlier stage
of cochlear development, i.e., P5, and so looking for early
degeneration biomarkers.
MATERIALS AND METHODS
Electronic Laboratory Notebooks Were Not Used.
Animals and Genotyping
Animals (Mus musculus) used in this study and bred at
the National Research Council–Institute of Biochemistry and
Cell Biology (CNR-IBBC), Infrafrontier/ESFRI–EuropeanMouse
Mutant Archive (EMMA), specific pathogen-free (SPF) barrier
unit (Monterotondo Scalo, Rome, Italy), were housed in
individually ventilated caging systems (Tecniplast, Gazzada,
Italy) at a temperature (T) of 21 ± 2◦C and relative humidity
(RH) of 55 ± 15% with 50–70 air changes per hour (ACH) and
under controlled (12:12 h) light–dark cycle (7 am−7 pm). Mice
had ad libitum access to water and a standard rodent diet (Emma
23, Mucedola, Settimo Milanese, Italy). Both male and female
homozygous Cx30−/− [EMMA ID (EM):00323] pups at P5, as
well as their wild-type P5 siblings (Cx30+/+), were used. The
background strain of these mice was C57BL/6J.




To visualize the deletion, primers specific for the lacZ region
(which flanks the deleted allele) were used in combination with
the corresponding wild-type forward primer:
lacZ 5′-AGCGAGTAACAACCCGTCGGATTC-3′.
Study Design
To construct the optimal experimental design and estimate the
minimum number of animals necessary for the experiments
(sample size of the groups), for each type of experiment and for
each genetically modified and control strain, we set probability
a = 5% = 0.05 for the type I error in the t-test. Then, fixing b
= 4a = 20% = 0.2 to obtain a test power of 1–b = 80% = 0.8,
we computed the number n of each of the two samples to be
compared using the following formula:
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with za/2 = 1.96 and zb = 0.842. Based on experiments
of the same type carried out in prior work, we quantified
the variability of the data (variance, σ 2) and established the
minimum difference, 1 = |µ1-µ2|, between averages that had
a biological significance. To minimize subjective bias, sample
identity (e.g., genotypes) was randomized by associating an
identification number to each sample before processing. One
sample was excluded from the analysis after microarray quality
control in miRNA expression profiling.
RNA Extraction and Evaluation
To study gene expression regulation by miRNAs during cochlear
development in Cx30−/− mice, we performed an integrated
functional genomics analysis (for data analysis flow chart, see
Supplementary Figure 1). We used both cochleae of n = 4
mice at P5 for each of the two genotypes and extracted total
RNA, including miRNAs using the Qiagen miRNeasy Mini Kit
(Qiagen, Hilden, Germany). The quality of RNA was evaluated
with Agilent 2100 Bioanalyzer, using the Small RNA assay
for miRNAs and the RNA 6000 Nano assay for mRNAs. All
of the eight samples thus obtained passed the quality control
and were processed for both types of profiling experiments as
described below.
miRNA Expression Profiling
miRNAs were labeled and purified starting from 100 ng of
total RNA of each sample and then hybridized on Mouse
miRNA Microarrays v.21.0, 8 × 60K (Agilent Technologies),
according to the miRNA Complete Labeling and Hyb Kit
Protocol (Version 3.1.1, August 2015). Microarrays were scanned
at 3-µm resolution using a SureScan Microarray Scanner System
(Agilent Technologies), and the Feature Extraction Software v.
11.5.1.1 (Agilent Technologies) was used for acquisition, data
extraction, and quality control analysis. After the evaluation of
quality control parameters for each scanned microarray image,
the raw data of three replicates for wild-type and four replicates
for knockout experimental conditions were analyzed using the
Gene-Spring GX v.14.5 software (Agilent Technologies), by
which fluorescence signal values were set at a threshold of 1,
log2 transformed, and normalized using the 90th percentile shift
method. The resulting data were baselined to the median of
all samples and quality-filtered on flags to include any probe
detected in 100% of biological replicates in at least one out of
the two tested experimental conditions. Significantly deregulated
miRNAs were identified using a moderate paired t-test and
Benjamini–Hochberg multiple testing correction. MicroRNA
profiling data were submitted to GEO (GSE151368).
Whole-Genome Transcription Profiling
Messenger RNA was labeled and purified starting from 100 ng
of total RNA of each sample and then hybridized on SurePrint
G3 Mouse Gene Expression v2 8 × 60K Microarrays (Agilent
Technologies), according to the One-Color Microarray-Based
Gene Expression Analysis—Low Input Quick Amp Labeling
kit protocol (Version 6.9.1, December 2015). Microarrays were
scanned at 3-µm resolution using a SureScan Microarray
Scanner System (Agilent Technologies), and the Feature
Extraction Software v. 11.5.1.1 (Agilent Technologies) was used
for acquisition, data extraction, and quality control analysis. The
raw data of all samples were analyzed using the Gene-Spring
GX v.14.5 software (Agilent Technologies). Fluorescence signal
values were set at a threshold of 1, log2 transformed, normalized
to the 75th percentile, baselined to the median of all samples,
and quality-filtered on flags to include any probe detected in
100% of biological replicates in at least one out of the two tested
experimental conditions. Differentially expressed genes (DEGs)
were identified by amoderate t-test andWestfall–Youngmultiple
testing correction. Data were submitted to GEO (GSE151367).
To perform gene set-focused expression analysis, we selected
two gene lists from the Gene Ontology (GO) Resource
knowledgebase (http://geneontology.org/) and its AmiGO tool
(http://amigo.geneontology.org/amigo) using “glutathione” and
“homocysteine” as keywords and filtering for M. musculus. The
two selected gene lists made up of glutathione-related genes
(n.86) and homocysteine-related (n.17) genes are, respectively,
available in Supplementary Tables 1, 2. To identify DEGs
between knockout and wild-type animals in each gene set-
focused list, a moderate t-test was applied without correction.
Functional Annotation and Enrichment
To functionally annotate DEGs and their products, we used the
DAVID Bioinformatics Resources v. 6.8 public database (https://
david.ncifcrf.gov/), together with the MetaCore software from
Clarivate Analytics (https://portal.genego.com/); Mouse Genome
Database (http://www.informatics.jax.org/); and the UniProt
knowledgebase (http://www.uniprot.org).
Integrated Analysis of miRNA and mRNA
Expression
To identify miRNA targets, we used the list of significant
differentially expressed miRNAs as input queries for the
DIANA-TarBase v7.0 tool (http://www.microrna.gr/tarbase),
which contains high-quality manually curated experimentally
validated miRNA–gene interactions inferred from published
data, using the species M. musculus and 30 validation methods
as filters. To annotate deregulated miRNAs with no validated
gene targets in the DIANA-TarBase, we used three tools
for miRNA target prediction, miRWalk v2.0 (http://zmf.umm.
uni-heidelberg.de/apps/zmf/mirwalk2/), miRDB (http://www.
mirdb.org/), and RNA22 v2.0 (https://cm.jefferson.edu/rna22/),
selecting target genes if present in two out of three of them
(Supplementary Table 3). The list of validated target genes for
each miRNA was used as input for the target network analysis
described below.
Network Analysis
To better clarify the interactions between gene targets of
deregulated miRNAs at protein level, an extended protein–
protein interaction (PPI) network was built using the STRING
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database v.10.0, visualized with the Cytoscape v.3.4.0 software,
and analyzed through its Network Analyzer plug-in. A network
was built using 2,914 miRNA target genes as seed molecules
(the entire workflow of analysis, setting, and filter values are
summarized in Supplementary Figure 2). A network topology
analysis was also performed on the base of topological parameters
to identify hub nodes or proteins having a higher degree of
connectivity reflecting their biological relevance. The final PPI
network was visualized on the base of node degree and edge
betweenness parameters. The relative importance of the network
proteins was determined based on the node centrality measure
and setting the topological parameter “node degree” to ≥10.
Likewise, values of edge betweenness (≥50) were mapped with
the edge size: high values of this parameter correspond to a large
edge size, where edge indicates interactions.
qPCR Quantitative Analysis of Cx26, Cx30,
and p53 Transcript Levels
RNA was extracted from whole cochleae freshly isolated from
Cx30+/+ and Cx30−/− mice at P5 using an RNeasy kit
(Cat. No. 74104, Qiagen, Milan, Italy). cDNA was obtained
by reverse transcription of mRNA with Oligo(dT)12–18 (Cat.
No. 18418012, Thermo Fisher Scientific, Milan, Italy) and
OmniScript Reverse Transcriptase (Cat. No. 205111, Qiagen) for
1 h at 37◦C. qPCR was performed on cDNA to amplify Cx26,
Cx30, and p53 and normalized to GAPDH expression (Pfaffl,
2001). Amplification was carried out using SYBR Green (Cat.
No. 4367659, Applied Biosystems) on the ABI 7700 sequence
detection system equipped with the ABI Prism 7700 SDS software
using the following amplification cycles:
50◦C, 2min;
95◦C, 10min;
95◦C, 15 sec; and
60◦C, 1min (40 cycles).











Animals were terminally anesthetized (ketamine, 70 mg/g for
males and 100 mg/g for females, and medetomidine 1 mg/g),
their cochleae were quickly removed, and samples were fixed
with 4% paraformaldehyde in phosphate-buffered saline (PBS)
at 4◦C and pH 7.5. For all immunofluorescence analyses,
control experiments were performed by omitting the primary
antibody during the processing of tissues, randomly selected
across experimental groups. Staining was absent in these control
cochlear samples, indicating neither autofluorescence nor lack of
antibody specificity (data not shown). Tissues from all groups
were always processed together to limit variability related to
antibody penetration, incubation time, post-sectioning age, and
condition of tissue.
Cx26 and Cx30 Immunofluorescence
Analysis
To evaluate Cx30 and Cx26 expression in cochlear structures,
cochleae from Cx30+/+ and Cx30−/− mice were decalcified
for 3 days in EDTA (0.3M). Specimens were included in
3% agarose dissolved in PBS and cut into 100-µm thickness
steps using a vibratome (VT 1000 S, Leica). Tissue slices were
permeabilized with 0.1% Triton X-100, dissolved in 2% bovine
serum albumin solution. Cx26 and Cx30 were immunolabeled
by overnight incubation at 4◦C with mouse monoclonal selective
antibodies (Cx26, 10µg/ml, Thermo Fisher, Cat. No. 335800;
Cx30, 10µg/ml, Thermo Fisher, Cat. No. MA5-35021) followed
by incubation with a goat anti-mouse IgG secondary antibody
(10µg/ml, Alexa Fluor R© 488, Thermo Fisher, Cat. No. A11029),
applied at room temperature (22–25◦C). F-actin was stained by
incubation with Alexa Fluor 568 phalloidin (1 U/ml, Thermo
Fisher, Cat. No. A12380), and nuclei were stained with 4′,6-
diamidino-2-phenylindole (DAPI, Thermo Fisher, Cat. No.
D1306) (1:200).
DHE Staining on Cochlear Tissue
Cryosections
Cochleae of Cx30+/+ and Cx30−/− terminally anesthetized mice
were quickly removed and fixed with 4% paraformaldehyde
in PBS at 4◦C. Next, cochleae were decalcified in 10% EDTA
(changed daily), incubated for 48 h in sucrose (30%), embedded
in OCT and cryosectioned (6µm). To evaluate the superoxide
amount, cochlear slices were incubated with 1mM DHE (Cat.
No. D23107, Thermo Fisher) in PBS for 30min at 37◦C,
embedded in antifade medium, and sealed with coverslips. DHE
was imaged using an ultrafast tunable mode-locked titanium:
sapphire laser (Chameleon; Coherent, 792 nm, 140 fs, 80 MHz)
coupled to a multiphoton microscope (Nikon) equipped with a
20× Plan Apo objective (0.75 NA, Nikon).
p53 and Sirt1 Immunofluorescence
Cochlear cryosections (6µm) were first treated with a blocking
solution (1% BSA, 0.5% Triton X-100, and 10% normal goat
serum in PBS 0.1M) and then incubated overnight at 4◦C with
a solution containing primary antibodies against p53 (Cat. No.
#2524, Cell Signaling Tech, Boston, MA USA, diluted 1:100 in
PBS) and Sirt1 (Cat. No. #9475, Cell Signaling Tech, diluted 1:100
in PBS). Next, specimens were incubated at room temperature
for 2 h in labeled-conjugated donkey anti-rabbit and/or anti-
mouse secondary antibody (Alexa Fluor 488 or 546, IgG, Thermo
Fisher, diluted 1:400 in PBS) and counterstained with DAPI (Cat.
No. D1306, Thermo Fisher; 1:500). Images were obtained with
the confocal laser scanning system (Nikon Ti-E, Confocal Head
A1 MP, Japan) equipped with an Ar/ArKr laser (for 488-nm
excitation), an HeNe laser (for 543-nm excitation), and a 20×
Plan Apo objective (0.75 NA, Nikon). DAPI was imaged by two-
photon excitation (740 nm, <140 fs, 90 MHz as detailed above).
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Extravasation Assay
Cx30+/+ and Cx30−/− mice at 3 months of age (3m) were
anesthetized by intraperitoneal injections of ketamine (35mg/kg)
and medetomidine (1 mg/kg). Next, 30 µl of dye-containing
solution (Texas RedTM dextran 70,000MV, Invitrogen, Cat. No.
1987295, dissolved in PBS at a concentration of 2.5 mg/ml) was
injected via the tail vein. After 3min, injected animals were
euthanized by cervical dislocation, cochleae were dissected in ice-
cold PBS, and the spiral ligament and SV were microdissected
from the rest of the cochleae. SV strips were detached from the
spiral ligament and mounted onto glass slides with a mounting
medium (FluorSaveTM Reagent, Cat. No. 345789-20M, Merck).
Images were obtained with a confocal laser scanning system
mentioned above equipped with a 20× dry objective (20X PL
Fluotar 0.5, NA, Leica). The fluorescent intensity of each area of
interest was quantified with ImageJ (version 2.0.0-rc-69/1.53c),
and statistics were computed using MATLAB R2019b on n = 3
mice for each genotype.
Western Immunoblots
Total proteins were extracted from cochleae of Cx30+/+ and
Cx30−/− animals (n = 8 animals per group). Cochleae were
dissected, collected on ice, stored at −80◦C, and homogenized
by using ice-cold RIPA buffer [Pierce: 50mMTris, 150mMNaCl,
1mMEDTA, 1%DOC, 1% Triton X-100, 0.1% SDS, 1× protease,
phosphatase-1, and phosphatase-2 inhibitor cocktails (Merck)].
The lysate was sonicated three times at 10Hz (Hielscher,
Ultrasound Technology UP50H/UP100H), centrifuged (13,000
rpm, 15min, 4◦C), and a 5-µl aliquot of the supernatant was
assayed to determine the protein concentration (microBCA kit,
Pierce). Reducing sample buffer was added to the supernatant,
and samples were heated to 95◦C for 5min. Protein lysates
(70 µg) were loaded onto Tris-glycine polyacrylamide gels
for electrophoretic separation. ColorburstTM electrophoresis
markers (Bio-Rad or Amersham) were used as molecular mass
standards. Proteins were then transferred onto nitrocellulose
membranes at 100V for 2 h at 4◦C in transfer buffer containing
25mM Tris, 192mM glycine, 0.1% SDS, and 20% methanol.
Membranes were incubated for 1 h with blocking buffer (5%
skim milk in TBST) and then incubated overnight at 4◦C with
the following primary antibodies: anti-Cx26 (mouse monoclonal,
Cat. No. 335800, Thermo Fisher Scientific); anti-Cx30 (mouse
monoclonal, Cat. No. MA5-35021, Thermo Fisher Scientific);
anti-p53 (mouse monoclonal, Cat. No. #2524, Cell Signaling
Tech); and anti-Sirt1 (rabbit polyclonal, Cat. No. 07-131, Merck
Millipore). After three 10-min rinses in TBST, membranes
were incubated for 1 h at RT horseradish peroxidase (HRP)-
conjugated mouse or rabbit secondary antibodies (Cat. No.
#7076 and Cat. No. #7074, respectively, Cell Signaling, 1:2,500).
Equal protein loading among individual lanes was confirmed by
reprobing the membranes with an anti-GAPDH (1:10,000, Cat.
No. ab8245, Abcam) or anti-tubulin mouse monoclonal antibody
(1:10,000, Cat. No. T6074, Sigma). Membranes were then washed
and bands visualized with an enhanced chemiluminescence
detection kit (Cat. No. K-12045-D50, Advansta). Protein
expression was evaluated and documented by using UVITEC
(Cambridge Alliance).
Statistical Analysis
For normally distributed data, statistical comparisons of means
data were made by Student’s two-tailed t-test using a worksheet
(Microsoft Office Excel 2017, Version 1.30), whereas ANOVA
and post-hoc comparison by Tukey’s test were used to analyze
the differences among group means using Statistica (version
6.0, StatSoft Inc.). The same software was also used to perform
the Mann–Whitney U-test on data that did not require the
assumption of normal distribution. Mean values are quoted ±
standard error of the mean (s.e.m.) where p < 0.05 indicate
statistical significance.
Study Approval
All experimental protocols involving the use of animals (M.
musculus) were approved by the Ethical Committee of Padua
University (Comitato Etico di Ateneo per la Sperimentazione
Animale, C.E.A.S.A., Project no. 58/2013, protocol no. 104230)
and the Italian Ministry of Health (DGSAF 0001276-P-
19/01/2016 and 68/2016-PR). Experimental procedures were
also agreed upon, reviewed, and approved by local animal
welfare oversight bodies and were performed with the approval
and direct supervision of the CNR-IBBC/Infrafrontier—Animal
Welfare and Ethical Review Body (AWERB), in accordance
with general guidelines regarding animal experimentation,
approved by the Italian Ministry of Health, in compliance with
the Legislative Decree 26/2014, transposing the 2010/63/EU
Directive on protection of animals used in research. This work
was also conducted based on recommendations from both
ARRIVE and PREPARE guidelines.
RESULTS
Identification of Early Degeneration
Biomarkers and Deregulated Molecular
Pathways at P5
Deregulation of miRNAs and the PPI Network of Their
Targets
By comparing miRNA expression profiles at P5 across genotypes
(Cx30−/− vs. Cx30+/+, see Materials and Methods and
Supplementary Figures 1, 2), we identified a total of 16
deregulated miRNAs. As illustrated in Figure 1 and reported
in Table 1, 9 out of 16 overexpressed miRNAs (miR-18a-5p,
miR-29b-3p, miR-29c-3p, miR-34a-5p, miR-34b-5p, miR-
141-3p, miR-181a-1-3p, miR-301a-3p, miR-376a-3p) have
been previously linked to apoptosis, oxidative stress, and
degeneration of the cochlea during aging. Thus, our results
suggest that connexin downregulation and/or dysfunction
determines a miRNA-mediated response during early post-natal
development, which may influence apoptosis, oxidative stress,
and degeneration processes and which can be detected already
at P5. This is much earlier than the time of cochlear sensory
epithelium degeneration, which occurs from P18 onwards in this
mouse model (Teubner et al., 2003).
The miR-29b/c controls glucocorticoid-induced apoptosis in
human plasmacytoid dendritic cells (Hong et al., 2013). In mice,
overexpression of miR-34a/c has been involved in drug-induced
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FIGURE 1 | Differentially expressed miRNAs. The pie chart shows significant changes in expression of 16 miRNAs, colored from light to dark gold according to their
fold change expression value in Cx30−/− mice vs. controls with normal Gjb6 alleles (Cx30+/+). The fold change values are shown in clockwise order starting from the
smallest one, indicating with an arrow the corresponding pie chart portion. Green tags highlight miRNAs already known as linked to apoptosis or deregulated in the
degeneration of the cochlea during aging. Two of these upregulated miRNAs were already found as deregulated in sensorineural diseases of the ear, i.e., miR-18a and
miR-376a, in mouse inner ear spatial expression patterns at P0, as previously reviewed (Ushakov et al., 2013; Mahmoodian sani et al., 2016). Moreover, the
upregulation of miR-29b was detected in mouse vestibular sensory epithelium at P2 (Elkan-Miller et al., 2011) and in the degeneration of the mouse OC during aging
(at 3m, 9m, and 16m compared to P21) (Zhang et al., 2013). Four other miRNAs, miR-29c, miR-34c, miR-141, miR-181a, and miR-301a, were previously described
as dysregulated in mouse OC with age-related hearing loss (Zhang et al., 2013). In particular, miR-29b/c, miR-34a/c, and miR-181a are reported as pro-apoptotically
deregulated in deafness due to aging (Khanna et al., 2011; Zhang et al., 2013).
hippocampal neurodegeneration (Cao et al., 2015), whereas
overexpression of miR-34a and miR-34c has been implicated
in drug-induced hearing loss (i.e., aminoglycoside-mediated
ototoxicity) linked to dose-dependent apoptosis of inner ear
cells (Yu et al., 2010). Finally, miR-141 and miR-181a were also
found differentially expressed in reactive oxygen species (ROS)-
damaged auditory cells (Wang et al., 2010).
To investigate the role of deregulated miRNAs, we
searched the databases for their known validated targets
(Supplementary Table 3). Five of these miRNAs (miR-34c, miR-
29b, miR-29c, miR-141, and miR-181a) were previously linked
to OC degeneration during age-related hearing loss (ARHL, also
known as presbycusis) (Zhang et al., 2013) and share Sirt1 as a
common silencing gene target, which they are known to inhibit
transcriptionally and/or post-transcriptionally in both humans
and mice (Table 1). Sirt1 encodes for the NAD+-dependent
deacetylase sirtuin 1 (Sirt1), a longevity modulator that exerts
its deacetylation activity on several targets related to oxidative
stress, inflammation, and apoptosis (Choi and Kemper, 2013).
Like other sirtuins, it regulates antioxidant defense mechanisms
involving antioxidant response elements (Singh et al., 2018).
Sirt1 expression decreases with aging, whereas its increment has
an antiaging role through multiple targets, including NFκB, p53,
and PGC1α. Therefore, Sirt1 activation is thought to prolong life
span and ameliorate age-related conditions (Chen et al., 2020b).
Two out of three of the miRNAs deregulated in our
model (miRNA-34b-5p and miRNA-34c-5p) belong to
the miRNA-34 family. Both are located in the same locus
and coordinately expressed as a miRNA cluster in both
humans and mice (Corney et al., 2007; He et al., 2007).
Prior work implicated the miR-34a/Sirt1/p53 signaling
pathway in cochlear cell apoptosis in an ARHL mouse
model (Xiong et al., 2015). Although we did not detect
differential expression of the miR-34a transcript in our model,
the seed sequence of miR-34a and miR-34c is identical,
suggesting that they can have the same targets (Rokavec
et al., 2014). In fact, as shown in Table 1, Sirt1 is a target also
of miR-34c.
We also generated a PPI network downstream of miRNA
deregulation, using network analysis of miRNA targets
(Figure 2A; the entire lists of network nodes and their hubs
are available in Supplementary Tables 4, 5, respectively).
In this scheme, the transcription factor p53 occupies a key
position as a network hub downstream of miRNA deregulation
(Figure 2B).
Taken together, these data suggested the involvement of a
Sirt1–p53 axis downstreammiRNA deregulation. Data regarding
gene and protein expression of Sirt1 and p53 are provided in
the sections below, related to the experimental validation of
selected targets.
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TABLE 1 | Deregulated miRNAs.
Up-regulated miRNAs in
Cx30KO vs. Cx30WT
miRNA detection miRNAs:Sirt1 known influence
34c Degeneration of the OC during ARHL
(Zhang et al., 2013); kanamycin-induced
apoptosis of inner ear cells (Yu et al.,
2010); ketamine-induced neurotoxicity in
neonatal mice hippocampus (Cao et al.,
2015); development, cancerous, and
non-cancerous diseases (Rokavec et al.,
2014).
Cognitive decline in mouse
hippocampus (Zovoilis et al.,
2011); neuropathic pain in rat
models with chronic constriction
injury of the sciatic nerve (Mo
et al., 2020).
Post-transcriptional inhibition
(Zovoilis et al., 2011);
transcriptional repression (Mo
et al., 2020).
29b Degeneration of the OC during ARHL
(Zhang et al., 2013); mammalian inner ear
(Elkan-Miller et al., 2011);
glucocorticoid-induced apoptosis in
human plasmacytoid dendritic cells (Hong
et al., 2013).
Cochlear hair cell apoptosis in
ARHL (Xue et al., 2016); oxidative
stress in ovarian cancer (Hou
et al., 2017); mouse embryonic
stem cells in response to ROS (Xu
et al., 2014).
Transcriptional repression (Xu
et al., 2014; Xue et al., 2016; Hou
et al., 2017).
29c Degeneration of the OC during ARHL
(Zhang et al., 2013);
glucocorticoid-induced apoptosis in







141 Degeneration of the OC during ARHL
(Zhang et al., 2013); oxidative stress in
auditory cells (Wang et al., 2010).
Autophagic response in
hepatocytes (Yang et al., 2017);
tumor suppressor in colorectal
carcinoma cells (Sun et al., 2019).
Transcriptional repression (Yang
et al., 2017; Sun et al., 2019).
181a Degeneration of the OC during ARHL
(Zhang et al., 2013); oxidative stress in
auditory cells (Wang et al., 2010);
Forskolin-treated basilar papillae (Frucht
et al., 2010); hair cell regeneration in the
avian auditory epithelium (Frucht et al.,
2011); apoptosis and survival in the brain
of calorie-restricted mice (Khanna et al.,
2011).
Hepatic insulin signaling and
glucose homeostasis (Zhou et al.,
2012).
Post-transcriptional inhibition
(Zhou et al., 2012).
The table lists deregulated miRNAs having Sirt1 as a common gene target and the model and pathologies in which their dysregulation has been detected. The mode of action of each
miRNA on Sirt1 is also listed.
Transcriptional Profiling
We singled out 81 DEGs, among which 57 encode 56
proteins (Supplementary Table 6), and 15 correspond
to non-coding RNAs (Supplementary Table 7). The co-
regulated expression of Cx30 and Cx26, previously described
at the mRNA level (Ortolano et al., 2008), emerged also
in these results, confirming that both connexins are
downregulated in Cx30−/− mice. Cx30−/− and Cx30+/+
mice expressed similar steady-state levels of Sirt1 and
Tp53 mRNA, suggesting that deregulation of the Sirt1–p53
axis could be controlled post-transcriptionally by miRNAs,
if present.
Our gene expression profiling also identified four
downregulated transcripts, Ang, Ang4, and Ang6, which
encode for three proteins belonging to the RNase A superfamily
(Cho et al., 2005) (Supplementary Table 6). Of note, angiogenin
(ANG) is a blood-vessel-inducing protein also expressed in
vascular endothelial cells (Shimoyama, 2011). In addition, Ang4
is known to have an angiogenic role (Crabtree et al., 2007).
Sirt1-dependent angiogenesis, where Sirt1 is a downstream
mediator of angiogenic signals regulating vascular remodeling,
was reported in mouse muscle vascularization. In particular, the
loss of endothelial Sirt1 resulted in an early decline of skeletal
muscle vascular density, while its overexpression had a protective
effect (Das et al., 2018). Moreover, we report the overexpression
of Tnfrsf10b (Supplementary Table 6), the tumor necrosis factor
receptor superfamily member 10b gene encoding for a death
receptor that is a known target of p53 (Speidel, 2010).
An increment of homocysteine caused by downregulation
of Bhmt, a gene encoding betaine-homocysteine S-
methyltransferase 1, was previously reported in P13 Cx30−/−
mice and correlated to endothelial dysfunction in the SV (Cohen-
Salmon et al., 2007). Here, we report downregulation of Bhmt
already at P5 (Supplementary Table 6). This zinc metalloenzyme
belongs to the trans-sulfuration pathway and catalyzes the
subsequent conversion of methionine to homocysteine and
cysteine, upstream of glutathione synthesis by glutathione
synthetase (Gss) (Garrow, 1996). Importantly, we recently
found deregulation of glutathione metabolism in Cx26−/−
mice, in which reduced release of glutathione from connexin
Frontiers in Cell and Developmental Biology | www.frontiersin.org 7 January 2021 | Volume 8 | Article 616878
Gentile et al. Strial Presbycusis in Cx30−/− Mice
FIGURE 2 | PPI network. (A) Extended PPI network obtained using the miRNA target genes as input data (seeds). (B) A focus on network hubs among which is the
transcription factor p53.
hemichannels has been also attributed to downregulation of Gss
(Fetoni et al., 2018), a glutathione-related gene.
In light of these results, we performed a gene set-focused
expression analysis on glutathione and homocysteine-
related genes (Supplementary Tables 1, 2). We detected
the downregulation of Gss and the dysregulation of two
other homocysteine-related genes, i.e., overexpression of C-1-
tetrahydrofolate synthase (Mthfd1) and downregulation of Bhmt.
The C-1-tetrahydrofolate synthase is a trifunctional protein
involved in the tetrahydrofolate interconversion pathway,
which interacts with the trans-sulfuration pathway at the
homocysteine level (Ducker and Rabinowitz, 2017; Sbodio et al.,
2019). Taken together, the results of this analysis support the
involvement of homocysteine metabolism dysregulation in
hearing loss.
MiR-34c-5p and Cx26
To identify possible transcriptional regulation between
deregulated miRNAs and mRNAs, we compared the two
lists of differentially expressed entities. This analysis yielded
a matched list of differentially expressed miRNAs and their
differentially expressed targets (Supplementary Table 8), among
which only the downregulation of Cx26 mediated by miR-34c-
5p showed inverse deregulation between the overexpressed
miRNA compared to its downregulated target gene. This direct
regulation is reported in the DIANA-TarBase v7.0 tool, as
inferred by crosslinking immunoprecipitation followed by
RNA-seq in mouse regenerating liver (Schug et al., 2013). This
miRNA–mRNA interaction was also predicted by the miRDB
and RNA22 v2.0 databases.
The integration of miRNA profiling and transcriptional
target analysis with gene expression profiling (taking into
account pairs of experimentally validated miRNA/mRNA
with an inverse correlation between their expression levels)
suggested that transcriptional repression of Cx26 could
be modulated by miR-34c-5p action. In addition, other
downregulated genes identified by our transcriptional profiling
(Supplementary Table 6) have sequences complementary to
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miR-34c/34b, including Trpa1, Trpm1, Ang, Ang4, and Ang6,
which are predicted interactors of miR-34c/miR-34b in the
RNA22 v2.0 database.
Oxidative Stress and Vascular Dysfunction
Immunofluorescence and Western Immunoblotting
Analyses at P5
To confirm the absence of Cx30 and drastically reduced
levels of Cx26 in the cochleae of Cx30−/− mice at P5,
compared to age-matched Cx30+/+ controls (wt), we performed
immunofluorescence studies (Supplementary Figure 3) and
Western blotting (Supplementary Figure 4) with selective
antibodies. The same approach was used to study the expression
levels of Sirt1 and Tp53 protein products. Our results confirmed
the downregulation of Sirt1 protein in the cochlear duct
of Cx30−/− mice, with the largest decrease observed in
the SV and OC (Figure 3 and Supplementary Figure 5),
suggesting that its miRNA-mediated inhibition can be
post-transcriptionally regulated in our model. In addition,
the elevated levels of miR-34c highlighted by expression
profiling correlated with a dramatic increment of p53
immunoreactivity in Cx30−/− cochleae (Figure 4 and
Supplementary Figure 6), suggesting that the Sirt1–p53 axis
was regulated downstream the post-transcriptional inhibition of
Sirt1 by upregulated miRNAs.
Analysis of Oxidative Stress in the Cochlea at P5
As mentioned above, age-related cochlear hair cell apoptosis
was linked to miR-34a/Sirt1/p53 action in a mouse model of
ARHL (Xiong et al., 2015). It is well-known that oxidative stress
is an aging hallmark and that an age-associated increase in
oxidative stress reduces endothelial Sirt1 protein expression
(Das et al., 2018). Therefore, we assayed oxidative stress
levels in our model as previously done for conditional
Cx26−/− mice (Fetoni et al., 2018). In Cx30+/+ cochlear
cryosections, superoxide levels (probed by DHE fluorescence,
see Materials and Methods) were generally faint and slightly
higher in spiral ganglion neurons (Figure 5A). In Cx30−/−
cochleae, superoxide levels were markedly higher and
particularly evident in spiral ganglion neurons, OC, and
SV (Figure 5B). Together, these data signal the occurrence
of early oxidative damage in Cx30−/− cochleae during
post-natal development.
FIGURE 3 | Sirt1 expression in Cx30+/+ and Cx30−/− cochleae at P5. (A–C) Representative images of immunofluorescence analysis with Sirt1-selective antibodies in
the cochlear sensory epithelium and lateral wall of Cx30+/+ and Cx30−/− (B,C) specimens. Images of negative control performed by omitting primary Sirt1 antibody
are shown in (A). (a1–c4) Higher magnification images of the OC and SV (dotted box in A–C) showing separately Sirt1 fluorescence (a1,b1,c1,a3,b3,c3) and merged
Sirt1/DAPI nuclei staining (a2,b2,c2,a4,b4,c4). Scale bar: 100µm. (D) Representative western blot immunoreactive bands quantifying the expression of Sirt1 in
Cx30+/+ and Cx30−/− cochlear lysates. (E) Histograms indicate optical density values (mean ± SEM) of the western blots normalized to tubulin levels. Full-scan
Western blot images are shown in Supplementary Figure 5.
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FIGURE 4 | p53 expression in Cx30+/+ and Cx30−/− cochleae at P5. (A,B) p53 immunoreactivity in the cochlear duct (A,B) and lateral wall (shown magnified in
A1,B1) of Cx30+/+ and Cx30−/− cochleae at P5. Scale bars: 20µm. (C) Representative western blot immunoreactive bands quantifying the expression of p53 in
Cx30+/+ and Cx30−/− cochleae (P5). (D) Optical density analysis (mean ± SEM) normalized to GAPDH. (E) qPCR quantitative analysis (mean ± SEM) of cochlear
p53 transcript levels in Cx30+/+ and Cx30−/− mice. Full-scan western blot images are shown in Supplementary Figure 6.
FIGURE 5 | Oxidative stress in Cx30+/+ and Cx30−/− cochleae at P5. (A,B) Representative cochlear cryosections stained with DHE showing superoxide production
(red fluorescence) in Cx30+/+ and Cx30−/− cochleae. Arrows indicate increased fluorescence intensity in principal cochlear structures: Stria vascularis, organ of Corti,
and spiral ganglion. Scale bar: 100µm.
Analysis of Vascular Dysfunction in the SV at 3m
The SV has the highest aerobic metabolic rate of all cochlear
structures, and its microvascular alterations contribute to
age-related degeneration and progressive decline of auditory
function. To examine the effects of oxidative damage on the
SV, we injected Texas Red dextran via the caudal vein in
Cx30−/− mice (at 3m) and age-matched Cx30+/+ controls and
examined dye fluorescence in SV whole mounts. Figure 6 shows
confocal images captured a few minutes after dye injection.
There was no sign of dye extravasation in control littermates
(Figures 6A,A1), whereas red fluorescence puncta were detected
outside SV capillaries in Cx30−/− samples (see arrows in
Figures 6B,B1), indicating disruption of the endothelial barrier
in adulthood. Also, as shown in Figure 6C, quantitative
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FIGURE 6 | Vascular dysfunction in Cx30−/− adult mice. (A,B) Representative images of freshly explanted SV from Cx30+/+ and Cx30−/− mice (3 months of age)
injected with a fluorescent Texas Red dextran (MW 70,000). Regions in the boxed areas are shown magnified in (A1,B1). Arrows indicate dye lumps that leaked out of
the vessels Cx30−/−. Scale bars: 30µm. (C) Quantification of Texas Red dextran fluorescence intensity (AU, arbitrary units) in SV of Cx30+/+ and Cx30−/− samples.
Data analysis was performed on n = 3 mice of each genotype; numbers above horizontal bars indicate p-values that were determined by the Mann–Whitney U-test,
as implemented in the MATLAB function ranksum. Through-focus image sequences (z-stacks) corresponding to the images shown in this figure are provided as
Supplementary Video 1 (Cx30+/+) and Supplementary Video 2 (Cx30−/−).
analysis of extravasation revealed a significant increase of
Texas Red dextran fluorescence emission in the extravascular
areas of SV of Cx30−/− mice compared to age-matched
Cx30+/+ controls.
DISCUSSION
In this work, we profiled miRNA and mRNA expression in
the developing cochlea of a DFNB1 mouse model with global
deletion of Cx30 and severely reduced Cx26 expression. Our
results highlight an early oxidative stress that, later on, culminates
in damage of the SV, a crucial vascularized epithelium of
the cochlear lateral wall. The key protein Sirt1 (a NAD-
dependent deacetylase protein) could mediate these processes,
triggered by a lack of connexins. Our data suggest that Sirt1
downregulation could be potentially induced by miRNA negative
influence and that it exerts its functions through p53, underlying
hearing impairment.
The reduction of EP caused by SV dysfunction is responsible
for strial ARHL in humans, as well as in mouse models of strial
presbycusis (Keithley, 2019; Ohlemiller, 2019). EP reduction
followed by mild hearing loss also affects a mouse model
of digenic heterozygous deficiency of Cx26 and Cx30, which
causes impairment of heterotypic intercellular gap junctions
coupling in the cochlear later wall (Mei et al., 2017). A recent
study on Cx30−/− mice (the same strain used in this article)
confirmed lack of EP at P18 preceded by failure of mitochondrial
function and ATP synthesis, increment of oxidative stress, and
dysregulated expression of proteins required for EP generation
in SV. That study also showed a significant increment of the pro-
apoptotic proteins Bax, Bad, and caspase-3 in the mouse cochlea,
suggesting a Bax-mediated mitochondrial cell death from P18
onward (Chen et al., 2020a). Data supporting the importance
of SV leakage underlying the pathogenic process of hearing
impairment are emerging also in a mouse model with conditional
deletion of Cx43 (Zhang et al., 2020).
We identified five overexpressed miRNAs (miR-34c, miR-
29b, miR-29c, miR-141, and miR-181a) linked to apoptosis,
degeneration of cochlea during aging and oxidative stress,
with Sirt1 as a common gene target of transcriptional and/or
post-transcriptional regulation (Figure 1 and Table 1). Although
Sirt1 mRNA steady-state levels were not altered in Cx30−/−
samples, our immunoassays confirmed an early Sirt1 expression
decrement in the cochleae of Cx30−/− mice compared to
controls. A miRNA-Sirt1 post-transcriptional influence has
been validated in specific models (Zovoilis et al., 2011; Zhou
et al., 2012; Bae et al., 2014). Therefore, Sirt1 could be post-
transcriptionally regulated by upregulated miRNAs, probably
miR-34c, miR-29c, and miR-181a, in the cochleae of Cx30−/−
mice at P5. In particular, miR-34c is our best candidate,
as our data suggest it could regulate the expression of
Cx26 (transcriptionally) and of Sirt1 (post-transcriptionally).
Moreover, miR-34a, p53 acetylation, and apoptosis increase with
aging in the cochleae of an ARHL mouse model, together with
an age-related decrement of Sirt1, linking the miR-34a/Sirt1/p53
axis to age-related apoptosis of cochlear cells (Xiong et al.,
2015). As previously mentioned, miR-34c shares an identical seed
sequence withmiR-34a, suggesting they can have the same targets
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(Rokavec et al., 2014). In fact, miR-34c/Sirt1 post-transcriptional
negative regulation was also described in a mouse model of
cognitive decline (Zovoilis et al., 2011). Another work correlated
age-dependent decrement of Sirt1 with increased miR-34a levels
in the cochlea of an ARHL mouse model, accompanied by
elevated hearing thresholds and loss of hair cells in the auditory
cortex (Pang et al., 2016). The circulating plasma level of miRNA-
34a was also significantly increased in human patients affected
by ARHL (Pang et al., 2016). Moreover, increased levels of
miR-34a were detected during endothelial cell senescence in
an in vitro model and in older mice, and the effect of miR-
34a upon senescence in endothelial cells was mediated by Sirt1
(Ito et al., 2010). It was also found that miR-34a levels increase
during aging while Sirt1 levels decrease in murine aortas, and
these changes correlated with an increased percentage of the
senescence marker p16 and with miR-34a/Sirt1-mediated arterial
dysfunctions (Badi et al., 2015). A correlation between SIRT1,
Nrf2 and ROS production and their modulation by miR-34a in
noise-induced hearing loss was reported also by Miguel et al.
(2018).
Of note, Sirt1 was found abundantly expressed in the inner
hair cells, strial marginal cells, and strial intermediate cells and
moderately expressed in the outer hair cells and neurons of
the auditory cortex and its significant reduction in a mouse
model of ARHL correlated with elevated hearing thresholds and
hair cell loss during aging (Xiong et al., 2014). In addition, the
antiaging effect of a serotonin 5-HT3 receptor antagonist was
assessed in a mouse model of induced senescence, resulting in
the upregulation of Sirt1 levels, increase of reduced glutathione
concentration, decrease of inflammation biomarkers, increase
of Bcl-2, and decrease of Bax, suggesting the regulation of
oxidative stress, inflammation, and apoptosis was mediated by
Sirt1 (Mirshafa et al., 2020).
The role of glutathione is particularly interesting, as we
detected the downregulation of the potent antioxidant enzyme
glutathione synthetase, Gss (Supplementary Table 1), also in
a Cx26 conditional knockout strain, accompanied by reduced
release of glutathione through connexin hemichannels. In
that work, we provided evidence of the consequent apoptosis
and oxidative damage in the cochlear duct, offering a link
between Cx26 monogenic hearing loss and ARHL (Fetoni
et al., 2018). Moreover, the potent natural antioxidant and
anti-inflammatory resveratrol is known to act on Sirt1, with
positive antiaging effects on both brain (Sarubbo et al., 2017;
Gomes et al., 2018) and vasculature (Kida and Goligorsky, 2016),
also protecting vascular endothelial cells from atherosclerosis
(a chronic inflammatory process associated with endothelial
dysfunction and oxidative stress) (Wu et al., 2020). An oxidative
stress increment in the SV was detected at P10 in Cx30−/−
mice, along with a deregulated expression of genes encoding for
catalases involved in oxidative stress in different cochlear regions
and time points (Chen et al., 2020a), in accord with the results
reported here.
Our immunoassay data indicate that Sirt1 decrement is
significant in SV at P5 (Figure 3), and Sirt1 is also known as a
regulator of angiogenic signaling during blood vessel growth,
downregulating genes involved in vascularization (Potente
et al., 2007). Here, we also reported the early downregulation
of Ang, Ang4, and Ang6 (Supplementary Table 6). Our
data also showed the deregulation of the trans-sulfuration
pathway (Supplementary Tables 2, 6), which is part of
the homocysteine metabolism upstream of glutathione
synthesis (Ducker and Rabinowitz, 2017; Sbodio et al.,
2019). Here, confirmed the downregulation of Bhmt, which
was previously linked to elevated levels of homocysteine in
the SV of Cx30−/− mice (Cohen-Salmon et al., 2007), and
FIGURE 7 | Pathogenic mechanism proposed. The scheme describes our results in a mouse model of inherited digenic deafness at P5, highlighting an early
involvement of a miRNA-mediated Sirt1–p53 axis as a nexus between oxidative stress in SV, metabolic dysregulation, and a hearing impairment occurring later in time
with vascular dysfunction, which are all hallmarks of aging.
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of Mthfr, another gene involved in homocysteine metabolism
and hearing loss, even if its role in ARHL is controversial.
Interestingly, hearing loss has been linked also to nutritional
imbalance and oxidative stress, promoting the use of dietary
supplementation as a nutritional therapy (Partearroyo et al.,
2017).
As noted above, Sirt1 is known to prevent oxidative damage
through different mechanisms, including the regulation of
mitochondrial dysfunction and oxidative stress by p53 and
NRF2 that in turn control the glutathione pathway (Singh
et al., 2018). We detected an early (i) relevant increment of
p53 immunoreactivity in the cochlear lateral wall (Figure 4),
(ii) oxidative stress damage concentrated in the SV at P5
(Figure 5) and culminating in an extravasation phenomenon
in strial explants of young adult Cx30−/− mice (Figure 6),
and as previously discussed, (iii) the downregulation of Gss
(Supplementary Table 1). Of note, our previous work on a
Cx26 conditional knockout mouse model highlighted accelerated
presbycusis caused by redox imbalance and dysregulation of
Nrf2 antioxidant-response element-dependent genes related to
glutathione metabolism (Fetoni et al., 2018). Moreover, Nrf2
seems to be also connected to the trans-sulfuration pathways
(Sbodio et al., 2019).
In support of the involvement of p53, encoded by the Trp53
gene, downstream of Sirt1, we also identified p53 as a hub of
the PPI network built using all the deregulated miRNA targets
of our model (Figure 2 and Supplementary Tables 4, 5). p53
is known to be a deacetylation target of Sirt1, exerting its
pro-aging activity through the inhibition of DNA damage and
stress-mediated cellular senescence. Consequently, inhibition of
p53 by activation of SIRT1 has been proposed as a potential
therapeutic strategy for aging-related diseases (Chen et al.,
2020b). p53 regulates caspase-mediated apoptosis through two
main mechanisms (and their cross talk): one is the extrinsic
receptor-mediated pathway, acting via a transcription-dependent
activity; the other is a transcription-independent activity that
promotes mitochondrial outer membrane permeability (Speidel,
2010). As for the latter, wild-type p53 has been shown to
localize at the endoplasmic reticulum (ER) and mitochondria-
associated membranes (MAMs), where it interacts with sarco/ER
Ca2+-ATPase (SERCA) pumps, modulating ER–mitochondria
cross talk and, in turn, Ca2+-dependent apoptosis (Giorgi
et al., 2015). In particular, activation and accumulation of
p53 at the ER/MAMs render cells more prone to death,
whereas absence of p53 leads to lower steady-state levels of
reticular Ca2+, reduced Ca2+ mobilization, and mitochondrial
accumulation evoked by agonist stimulation (ATP) or oxidative
stress (Giorgi et al., 2016). In support of the role of p53
in our model, we detected a relevant upregulation of the
Tnfrsf10b at P5 (Supplementary Table 6), which encodes a
death receptor also known as Dr5 that is a target of the
transcription-dependent apoptotic activity of p53 (Speidel, 2010).
Moreover, we already discussed a recent report suggesting that
high levels of ROS may promote a Bax-mediated mitochondrial
cell death from P18 onward in a Cx30−/− mouse model
(Chen et al., 2020a). Taken together, these data suggest the
involvement of the Sirt1–p53 axis as a nexus between (so far
unrelated observations underlying) hearing impairment, vascular
dysfunction, and aging in a mouse model of inherited digenic
deafness (Figure 7).
In summary, our results suggest that inner ear connexin
dysfunction in the Cx30−/− mouse model of DFNB1 promotes
oxidative stress, apoptosis, and degeneration during early post-
natal development, ensuing in cochlear vascular dysfunction
later on in life, which are all hallmarks of ARHL. Our analysis
links these pathological modifications to a Sirt1–p53 axis and its
possible miRNA regulation. Strial atrophy is a known cause of
sensorineural hearing loss (Pauler et al., 1988), and the crucial
role of ion flow in SV and the production and regulation
of cochlear endolymph and the endolymphatic potential is
well-established. Moreover, studies in different rodent species
showed age-related strial degeneration, coupled with an age-
related reduction in the endolymphatic potential (Fetoni et al.,
2011; Kujawa and Liberman, 2019). Furthermore, recent work
on patients affected by severe ARHL (both sporadic and
familial cases) demonstrated that ultrarare gene variants are
causally linked to presbycusis where they were already known
to cause dominant early-onset monogenic deafness (Boucher
et al., 2020). In addition, Cx26 and Cx30 gap junctions are
known to connect intermediate and basal cells of cochlear
SV and play an important role in the generation of the
endocochlear potential (Wangemann, 2006). It remains to be
determined whether the observed vascular dysfunction is caused
by reduction of Cx26 alone or in combination with Cx30. Further
analysis is also necessary to extend our integrative analysis
and directly validate miRNA/mRNA interaction. Although
such studies pose important experimental challenges in the
auditory organ, future experiments may help to identify novel
therapeutic strategies.
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